XML 21 R8.htm IDEA: XBRL DOCUMENT v3.25.4
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Retained Earnings (Deficit)
Accumulated Other Comprehensive Income (Loss)
Treasury Stock
Noncontrolling Interest
Beginning Balance (in shares) at Dec. 31, 2022   302,326,000          
Beginning Balance at Dec. 31, 2022 $ 1,665,523 $ 3,023 $ 3,202,973 $ (87,394) $ 0 $ (1,453,079) $ 0
Net income (loss) 245,952     246,292     (340)
Noncontrolling interest 8,729           8,729
Foreign currency translation adjustment 472       472    
Issuance of common stock - Ulterra acquisition (in shares)   34,900,000          
Issuance of common stock - Ulterra acquisition 521,406 $ 349 521,057        
Issuance of common stock - NexTier merger (in shares)   172,092,000          
Issuance of common stock - NexTier merger 2,565,895 $ 1,720 2,564,175        
Issuance of replacement awards related to NexTier merger 72,413   72,413        
Issuance of restricted stock (in shares)   1,077,000          
Issuance of restricted stock 0 $ 10 (10)        
Vesting of restricted stock units (in shares)   6,380,000          
Vesting of restricted stock units 0 $ 64 (64)        
Stock-based compensation 46,750   46,750        
Payment of cash dividends (100,034)     (100,034)      
Dividend equivalents (1,829)     (1,829)      
Purchase of treasury stock (204,596)         (204,596)  
Ending Balance (in shares) at Dec. 31, 2023   516,775,000          
Ending Balance at Dec. 31, 2023 4,820,681 $ 5,166 6,407,294 57,035 472 (1,657,675) 8,389
Net income (loss) (966,399)     (968,031)     1,632
Foreign currency translation adjustment (3,056)       (3,056)    
Issuance of restricted stock (in shares)   719,000          
Issuance of restricted stock 0 $ 7 (7)        
Vesting of restricted stock units (in shares)   3,291,000          
Vesting of restricted stock units 0 $ 33 (33)        
Stock-based compensation 46,352   46,352        
Payment of cash dividends (126,791)     (126,791)      
Dividend equivalents (1,551)     (1,551)      
Purchase of treasury stock $ (293,392)         (293,392)  
Ending Balance (in shares) at Dec. 31, 2024 520,784,783 520,785,000          
Ending Balance at Dec. 31, 2024 $ 3,475,844 $ 5,206 6,453,606 (1,039,338) (2,584) (1,951,067) 10,021
Net income (loss) (93,054)     (93,635)     581
Distributions to noncontrolling interest (4,425)           (4,425)
Foreign currency translation adjustment 1,429       1,429    
Vesting of restricted stock units (in shares)   2,952,000          
Vesting of restricted stock units 0 $ 30 (30)        
Stock-based compensation 39,286   39,286        
Payment of cash dividends (122,453)     (122,453)      
Dividend equivalents (2,265)     (2,265)      
Purchase of treasury stock $ (69,647)         (69,647)  
Ending Balance (in shares) at Dec. 31, 2025 523,736,898 523,737,000          
Ending Balance at Dec. 31, 2025 $ 3,224,715 $ 5,236 $ 6,492,862 $ (1,257,691) $ (1,155) $ (2,020,714) $ 6,177